A strategy to build and validate a prognostic biomarker model based on RT-qPCR gene expression and clinical covariates

Construction and validation of a prognostic model for survival data in the clinical domain is still an active field of research. Nevertheless there is no consensus on how to develop routine prognostic tests based on a combination of RT-qPCR biomarkers and clinical or demographic variables.